Strides Pharma Science Ltd - Share Price

STAR

Open

397.00

Prev. Close

396.00

Turnover (lac.)

3,139

Day's High

408.50

Day's Low

396.00

52 Week's High

547.65

52 Week's Low

268.00

Book Value

376

Face Value

10

Mkt Cap (Cr.)

3,569

P/E

31.94

EPS

12.47

Divi. Yield

3.52

Strides Pharma Science LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Strides Pharma Science LtdNews & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd474.2535.53114,076.381,155.850.842,750.41101.68
Dr Reddys Laboratories Ltd4,071.2523.0467,695.18502.800.612,837.90914.23
Divis Laboratories Ltd2,390.1050.0763,599.64360.730.671,390.49266.77
Cipla Ltd648.1522.5352,212.05604.570.623,042.01215.85
Aurobindo Pharma Ltd745.6527.1543,655.36419.070.343,258.10206.07

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Strides Pharma Science LtdSummary & Reports

Strides Pharma Science Limited is an integrated manufacturer and exporter of finished pharmaceutical dosage forms for both branded and generic. The company manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals. Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semi-solids. They undertake contract research and manufacturing of specialty chemicals. ... More

Registered Office

No 201 Devavrata Sector 17,Vashi,Navi Mumbai, Maharashtra,400703

Tell. : +91-22-27892924/27893199
Website : http://www.stridesarco.com
Email : investors@stridesshasun.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com

Latest Release by strides-pharma-science-ltd

View

- <

Reco. Price

May 21,2020 01:38 PM

Target Price

Target Returns:

0.00%

Result Express

Strides Arcolab Ltd's Q3FY19 consolidated net profit declines 38.09% yoy to Rs30.83cr : In-line with Estimates

May 29, 2020 07:50 PM

The company’s consolidated revenue stood at Rs794.50cr, up 6.07% yoy and 8.44% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    20 May 2020

    Annc. Date

    11 May 2020

    Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company... More

  • Purpose

    EGM

    Exp. Date

    20 Feb 2020

    Annc. Date

    17 Jan 2020

    COM 20/02/2020National Company Law Tribunal convened meeting of Equity Shareholders of the Company t... More

  • Purpose

    Board Meeting

    Exp. Date

    30 Jan 2020

    Annc. Date

    23 Jan 2020

    Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company... More